Introduction

Please Categorize The Statements According To The Type Of Hypersensitivity

PL
idmbestpractices.ca
10 min read
Please Categorize The Statements According To The Type Of Hypersensitivity
Please Categorize The Statements According To The Type Of Hypersensitivity

Introduction

Hypersensitivity reactions are exaggerated or inappropriate immune responses that cause tissue damage and clinical disease. The classic classification, proposed by Coombs and Gell, divides these reactions into four types—Type I (immediate, IgE‑mediated), Type II (antibody‑dependent cytotoxic), Type III (immune‑complex mediated), and Type IV (cell‑mediated delayed). When studying immunology, students often encounter a list of clinical statements or laboratory findings and must determine which hypersensitivity type each belongs to. This article systematically categorizes common statements according to the four hypersensitivity groups, explains the underlying mechanisms, and provides helpful mnemonics for quick recall.


Type I – Immediate (IgE‑Mediated) Hypersensitivity

Key Features

  • Trigger: Allergen cross‑links IgE bound to FcεRI on mast cells and basophils.
  • Onset: Seconds to minutes after exposure.
  • Effector molecules: Histamine, leukotrienes, prostaglandins, platelet‑activating factor.
  • Clinical picture: Urticaria, allergic rhinitis, asthma, anaphylaxis, food allergy.

Statements Belonging to Type I

# Statement Why it fits Type I
1 “Rapid onset of wheezing and bronchoconstriction after exposure to cat dander.Plus, ” Tryptase is released from activated mast cells, a hallmark of IgE‑mediated degranulation. Here's the thing —
8 “Urticaria appearing 5 minutes after consuming peanuts. ” Immediate bronchospasm results from mast‑cell‑derived mediators after IgE cross‑linking. On the flip side, ”
2 “Elevated serum tryptase measured 2 h after a severe allergic reaction.
7 “Bronchial hyper‑responsiveness that worsens after exposure to pollen, reversible with a short‑acting β2‑agonist.Also,
6 “Serum IgE level markedly higher than normal in a patient with atopic dermatitis. In practice, ” Classic IgE‑driven allergic rhinitis; symptoms are mediated by histamine. ”
3 “Positive skin prick test showing a wheal‑and‑flare reaction within 15 minutes.
5 “Seasonal sneezing, itchy eyes, and clear rhinorrhea that improve with antihistamines.” IgE‑mediated mast cell activation amplifies airway smooth‑muscle tone.
4 “Anaphylactic shock following intravenous administration of contrast dye.” Systemic release of vasoactive mediators from IgE‑sensitized mast cells leads to hypotension and airway collapse. ”

Quick Mnemonic

“WHEE‑FAST”Wheals, Histamine, Eosinophils, Elevated IgE, Fever (rare), Asthma, Shock, Tryptase.


Type II – Antibody‑Dependent Cytotoxic (IgG/IgM)

Key Features

  • Trigger: Antibodies bind antigens on cell surfaces or extracellular matrix.
  • Effector mechanisms: Complement activation (classical pathway), antibody‑dependent cellular cytotoxicity (ADCC), opsonization.
  • Typical targets: Red blood cells, platelets, neutrophils, basement membrane.
  • Clinical picture: Autoimmune hemolytic anemia, Goodpasture’s syndrome, rheumatic fever, hemolytic disease of the newborn, drug‑induced thrombocytopenia.

Statements Belonging to Type II

# Statement Why it fits Type II
1 “Positive direct Coombs test in a patient with jaundice and anemia.
8 “Myocardial injury following administration of anti‑streptolysin O antibodies in rheumatic fever.” Detects IgG or complement on patient’s RBCs, indicating antibody‑mediated hemolysis. ”
5 “Hemolysis triggered by the administration of a monoclonal antibody that binds CD20 on B‑cells.
7 “Rapid drop in hemoglobin after a transfusion of mismatched blood, accompanied by complement consumption.Because of that, ” Drug‑dependent antibodies target platelet surface antigens, leading to destruction. That's why ”
3 “Neonatal jaundice due to maternal anti‑Rh(D) IgG crossing the placenta.That said,
6 “Skin blistering after taking a sulfonamide, with IgG deposition at the dermal‑epidermal junction. In practice, ” Drug‑induced pemphigus‑like reaction mediated by IgG autoantibodies.
2 “Renal biopsy showing linear IgG deposition along the glomerular basement membrane.Consider this:
4 “Thrombocytopenia occurring after exposure to quinine, with platelet‑bound IgG detected. ” Cross‑reactive antibodies attack cardiac tissue (molecular mimicry).

Quick Mnemonic

“C‑C‑A‑P”Complement, Cytotoxicity, Antibody on Plasma‑membrane.


Type III – Immune‑Complex Mediated

Key Features

  • Trigger: Soluble antigen–antibody (IgG or IgM) complexes form in circulation and deposit in vessel walls or tissues.
  • Effector mechanisms: Complement activation (C3a, C5a), neutrophil recruitment, release of lysosomal enzymes, tissue inflammation.
  • Clinical picture: Systemic lupus erythematosus (SLE), serum sickness, post‑streptococcal glomerulonephritis, Arthus reaction, rheumatoid arthritis (immune‑complex component).

Statements Belonging to Type III

# Statement Why it fits Type III
1 “Low‑grade fever, arthralgia, and rash 7 days after receiving an antiserum.So ” Serum sickness is a classic immune‑complex disease occurring 1–2 weeks post‑exposure. Now,
2 “Granular (“starry‑sky”) deposits of IgG and C3 along the glomerular basement membrane on immunofluorescence. Also, ” Indicates immune‑complex deposition in post‑streptococcal GN.
3 “Elevated circulating C3a and C5a levels in a patient with vasculitic rash after a viral infection.” Anaphylatoxins are generated by complement activation by immune complexes.
4 “Joint swelling with neutrophil‑rich synovial fluid and deposition of fibrin‑rich immune complexes.And ” Rheumatoid arthritis flare can involve type III mechanisms.
5 “Urticarial plaques that appear 24 h after subcutaneous injection of a foreign protein, persisting for 48 h.” Arthus reaction—local immune‑complex deposition with complement‑mediated inflammation.
6 “Positive anti‑dsDNA antibodies and decreased serum complement levels in a patient with malar rash.” SLE activity is driven by circulating immune complexes that consume complement.
7 “Kidney biopsy showing subepithelial “hump” deposits on electron microscopy.” Classic for immune‑complex mediated post‑infectious GN.
8 “Hypersensitivity pneumonitis characterized by granulomas and lymphocytic alveolitis after chronic exposure to bird droppings.” Immune complexes contribute to the inflammatory milieu in hypersensitivity pneumonitis.

Quick Mnemonic

“G‑R‑A‑V‑E”Granular deposits, Reactive (fever, rash), Anaphylatoxins, Vasculitis, Excess complement consumption.

Continue exploring with our guides on write a story that would explain the graph below and why a chemical equation must be balanced.


Type IV – Cell‑Mediated (Delayed) Hypersensitivity

Key Features

  • Trigger: Sensitized T‑lymphocytes (CD4⁺ Th1, CD8⁺ cytotoxic) recognize antigen presented by MHC on APCs.
  • Onset: 48–72 hours after exposure.
  • Effector mechanisms: Cytokine release (IFN‑γ, TNF‑α), macrophage activation, cytotoxic T‑cell killing, granuloma formation.
  • Clinical picture: Contact dermatitis, tuberculin skin test (PPD), graft‑versus‑host disease, type 1 diabetes mellitus, multiple sclerosis, chronic transplant rejection.

Statements Belonging to Type IV

# Statement Why it fits Type IV
1 “Erythema and vesiculation at the site of nickel‑containing jewelry after 48 h.” Host T cells recognize donor HLA antigens, leading to delayed rejection. So
3 “Granulomatous inflammation with caseating necrosis in lung tissue of a patient with active tuberculosis. ” Poison‑ivy dermatitis is a T‑cell‑mediated delayed reaction. Here's the thing —
5 “Chronic graft rejection characterized by intimal thickening and infiltrating CD4⁺ T cells. In real terms,
8 “Multiple sclerosis lesions on MRI correlating with perivascular CD8⁺ T‑cell infiltrates. In practice, ” Classic contact dermatitis mediated by sensitized T cells. ”
6 “Positive lymphocyte transformation test after exposure to a new antiepileptic drug.Day to day,
7 “Skin biopsy showing epidermal spongiosis and a perivascular lymphocytic infiltrate after topical application of poison ivy. ” CD4⁺ Th1 cells activate macrophages, forming granulomas. ”
4 “Beta‑cell destruction in the pancreas associated with CD8⁺ cytotoxic T‑cell infiltration in newly diagnosed type 1 diabetes.
2 “Induration of 12 mm measured 72 h after intradermal injection of purified protein derivative (PPD).” Autoimmune demyelination driven by cell‑mediated immunity.

Quick Mnemonic

“C‑A‑R‑D‑S”Cytotoxic T cells, Arthritis/autoimmunity, Rejection, Delayed skin test, Spongiotic dermatitis.


Comparative Table: Quick Reference

Hypersensitivity Type Dominant Immunoglobulin / Cells Typical Onset Main Pathogenic Mechanism Representative Clinical Statements
Type I IgE on mast cells/basophils Seconds–minutes IgE cross‑link → degranulation → histamine, leukotrienes Wheezing after cat dander, anaphylaxis to contrast, positive skin prick
Type II IgG/IgM binding cell‑surface antigens Hours Complement‑mediated lysis or ADCC Positive Coombs test, neonatal hemolysis, Goodpasture’s linear IgG
Type III IgG/IgM immune complexes 6–24 h (often days) Complex deposition → complement → neutrophil inflammation Serum sickness, post‑streptococcal GN, SLE low complement
Type IV Sensitized T cells (CD4⁺ Th1, CD8⁺) 48–72 h Cytokine‑driven macrophage activation, cytotoxicity, granuloma Contact dermatitis, PPD induration, TB granulomas

Frequently Asked Questions

1. Can a single disease involve more than one type of hypersensitivity?

Yes. Systemic lupus erythematosus primarily reflects Type III immune‑complex injury, but renal involvement may also show Type II features (anti‑GBM antibodies). Rheumatoid arthritis has both Type III (immune complexes) and Type IV (T‑cell‑driven synovial inflammation) components.

2. Why is complement consumption a clue for Type III reactions?

Immune complexes activate the classical complement pathway, leading to consumption of C3 and C4. Low serum complement levels are therefore a laboratory hallmark of active Type III disease (e.g., SLE flare).

3. How do drug‑induced hypersensitivities differ among types?

  • Type I – Immediate urticaria or anaphylaxis (e.g., penicillin).
  • Type II – Cytopenias caused by drug‑dependent antibodies (e.g., quinine‑induced thrombocytopenia).
  • Type III – Serum‑sickness–like reactions after heterologous antiserum.
  • Type IV – Delayed maculopapular rash or Stevens‑Johnson syndrome mediated by T cells.

4. What laboratory tests help differentiate the types?

  • IgE level and tryptase – Type I.
  • Direct/indirect Coombs test, flow cytometry for bound IgG – Type II.
  • Complement levels (C3, C4), immune‑complex assays, cryoglobulins – Type III.
  • Skin patch test, intradermal PPD, lymphocyte transformation test – Type IV.

5. Are treatment strategies type‑specific?

Generally, antihistamines, cromolyn, and epinephrine target Type I; plasmapheresis, IVIG, and complement inhibitors are useful for Type II/III; corticosteroids and immunosuppressants (e.g., calcineurin inhibitors) are mainstays for Type IV. Tailoring therapy to the underlying mechanism improves outcomes.


Conclusion

Understanding the four classic hypersensitivity types provides a powerful framework for interpreting clinical statements, laboratory data, and histopathology. By categorizing each statement according to its immunologic pathway—IgE‑mediated mast cell degranulation (Type I), antibody‑dependent cytotoxicity (Type II), immune‑complex deposition (Type III), or T‑cell‑driven delayed response (Type IV)—students and clinicians can quickly pinpoint the underlying mechanism, anticipate complications, and select appropriate diagnostic tests and therapies. Memorizing the concise mnemonics (WHEE‑FAST, C‑C‑A‑P, G‑R‑A‑V‑E, C‑A‑R‑D‑S) and referring to the comparative table will reinforce learning and enable accurate, rapid decision‑making in both academic and clinical settings.

New

Latest Posts

Related

Related Posts

Thank you for reading about Please Categorize The Statements According To The Type Of Hypersensitivity. We hope this guide was helpful.

Share This Article

X Facebook WhatsApp
← Back to Home
ID

idmbestpractices

Staff writer at idmbestpractices.ca. We publish practical guides and insights to help you stay informed and make better decisions.